Company DA32 Life Science Tech Acquisition Corp.
Equities
DALS
US23312M1062
Investment Holding Companies
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Kafka
CEO | Chief Executive Officer | 54 | 01/21/01 |
Chris Wolfe
DFI | Director of Finance/CFO | 44 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
E. Hrusovsky
BRD | Director/Board Member | 63 | 27/21/27 |
Keith Crandell
BRD | Director/Board Member | 63 | 27/21/27 |
Nicolas Roelofs
BRD | Director/Board Member | 66 | 27/21/27 |
Steven Kafka
CEO | Chief Executive Officer | 54 | 01/21/01 |
Angela Lai
BRD | Director/Board Member | - | 27/21/27 |
Director/Board Member | 42 | 27/21/27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,000,000 | 0 | 0 | 77.01 % |
Stock B | 1 | 20,650,000 | 19,752,807 ( 95.66 %) | 0 |
Company contact information
DA32 Life Science Tech Acquisition Corp.
345 Park Avenue South 12th floor
10010, New York
+
![address DA32 Life Science Tech Acquisition Corp.(DALS)](https://cdn.zonebourse.com/static/address/125228566.png)
1st Jan change | Capi. | |
---|---|---|
+108.23% | 700.7Cr | |
+2.71% | 99Cr | |
+51.02% | 98Cr | |
+2.39% | 67Cr | |
-.--% | 60Cr | |
-2.15% | 59Cr | |
+10.28% | 54Cr | |
-.--% | 50Cr | |
+4.83% | 47Cr |